Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics
Pharmacopsychiatry · 07.10.2026
DOI: 10.1055/a-2959-4334 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Pharmacopsychiatry, erschienen am 07.10.2026. Verfasst von Seoyoung Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University Bundang Hospital, Department of Neuropsychiatry, Korea (the Republic of), Seongnam-si. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Otsuka Korea Pharmaceutical.
Abstract (Originalsprache)
Antipsychotic-induced weight gain and metabolic disturbance are common in schizophrenia, but liability varies across agents. Aripiprazole has a relatively favorable metabolic profile, yet evidence on aripiprazole once-monthly, its long-acting injectable formulation, remains limited. We hypothesized that switching from a higher liability antipsychotic would yield a greater weight reduction than switching from a lower liability agent. This 16-week, prospective, open-label, multicenter study enrolled patients with stable schizophrenia. Participants were stratified by the metabolic liability of their prior oral antipsychotic (high vs. low). Participants received aripiprazole once-monthly 400 mg intramuscularly every 4 weeks, with cross-titration of the prior agent. Anthropometric and metabolic parameters were assessed every 4 weeks from baseline. Weight changes at week 16 were the principal outcome, and all analyses were exploratory. Mixed models for repeated measures evaluated changes over time, adjusting for covariates. Among the 151 participants (100 low-risk and 51 high-risk participants), weight, body mass index, and waist circumference decreased significantly in the high-risk group only, and more high-risk patients reached clinically meaningful improvement. Most lipid and glycemic indices changed little, although low-density lipoprotein cholesterol and total cholesterol decreased in both groups. Psychiatric symptoms remained stable. In a subgroup switched from oral aripiprazole (n=73), anthropometric and metabolic parameters were all unchanged. In patients previously exposed to high-metabolic-risk antipsychotics, switching to aripiprazole once-monthly was associated with short-term reductions in weight and central adiposity—consistent with the reversal of the prior agents' metabolic burden—while psychiatric stability was maintained. Longer-term studies are needed to confirm their durability and clinical significance.
Autor:innen und Institutionen
- Seoul National University Bundang Hospital, Department of Neuropsychiatry, Korea (the Republic of), Seongnam-si.
- Nowon Eulji University Hospital, Department of Psychiatry, Korea (the Republic of), Nowon-gu.
- Eulji University School of Medicine, Department of Psychiatry, Korea (the Republic of), Daejeon.
- Chungnam National University Hospital, Department of Psychiatry, Korea (the Republic of), Daejeon.
- Chungnam National University, Brain Research Institute, Korea (the Republic of), Yuseong-gu.
- Hanyang University Guri Hospital, Department of Psychiatry, Hanyang University College of Medicine, Korea (the Republic of), Guri-si.
ORCID-Profile: Ji-Woon Jeong, Euitae Kim
Förderung
- Otsuka Korea Pharmaceutical
Zitieren
APA
Kim, S., Lee, K. Y., Chee, H. S., Choi, J., Kim, Y. H., Kim, W. H., Lee, H. J., Jeong, J. W., Lee, Y. S., Park, I. H., Kim, J. W., Oh, H. S., Kim, M. D., Kim, E., & Kwon, J. S. (2026). Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics. Pharmacopsychiatry. https://doi.org/10.1055/a-2959-4334
Vancouver
Kim S, Lee KY, Chee HS, Choi J, Kim YH, Kim WH, et al. Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics. Pharmacopsychiatry. 2026. doi:10.1055/a-2959-4334
BibTeX
@article{Kim2026,
author = {Kim, Seoyoung and Lee, Kyu Young and Chee, Hyun Seung and Choi, Joonho and Kim, Young-Hoon and Kim, Won-Hyoung and Lee, Heon-Jeong and Jeong, Ji-Woon and Lee, Yu Sang and Park, Il Ho and Kim, Jong Woo and Oh, Hong Seok and Kim, Moon-Doo and Kim, Euitae and Kwon, Jun Soo},
title = {Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics},
journal = {Pharmacopsychiatry},
year = {2026},
doi = {10.1055/a-2959-4334}
}
EUVIMED